Valion Bio, Inc. SEC filings VBIO
Valion Bio, Inc. has 403 filings in SEC EDGAR's recent list, going back to Sep 10, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 21, 2026 | — |
| S-3 | Shelf registration | Oct 16, 2026 | — |
| S-3 | Shelf registration | Oct 8, 2026 | — |
| S-1 | Registration statement | Jul 17, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| S-1 | Registration statement | Apr 13, 2026 | — |
| 424B3 | Prospectus | Jan 20, 2026 | — |
| 424B3 | Prospectus | Jan 20, 2026 | — |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 424B3 | Prospectus | Nov 6, 2025 | — |
| S-3 | Shelf registration | Oct 17, 2025 | — |
| 424B3 | Prospectus | Sep 5, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| 424B3 | Prospectus | Jul 30, 2025 | — |
| S-1/A | Amended registration statement | Jul 25, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| S-1 | Registration statement | Jun 6, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| S-1 | Registration statement | May 9, 2025 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 424B5 | Prospectus supplement | Sep 13, 2024 | — |
| 424B4 | Prospectus | May 13, 2024 | — |
| S-1/A | Amended registration statement | May 8, 2024 | — |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| S-1 | Registration statement | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | Aug 4, 2023 | — |
| 424B5 | Prospectus supplement | Jul 17, 2023 | — |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| 424B5 | Prospectus supplement | Jul 11, 2023 | — |
| 424B5 | Prospectus supplement | Jul 7, 2023 | — |
| 424B4 | Prospectus | Feb 10, 2023 | — |
| S-1/A | Amended registration statement | Feb 1, 2023 | — |
| S-3 | Shelf registration | Feb 1, 2023 | — |
| S-1/A | Amended registration statement | Jan 6, 2023 | — |
| S-1/A | Amended registration statement | Dec 20, 2022 | — |
| S-1/A | Amended registration statement | Dec 9, 2022 | — |
| S-1 | Registration statement | Oct 26, 2022 | — |
| S-8 | Employee stock plan registration | Nov 12, 2021 | — |
| 424B4 | Prospectus | Nov 12, 2021 | — |
| S-1/A | Amended registration statement | Oct 29, 2021 | — |
| S-1/A | Amended registration statement | Sep 23, 2021 | — |
| S-1/A | Amended registration statement | Sep 9, 2021 | — |
| S-1/A | Amended registration statement | Aug 12, 2021 | — |
| S-1 | Registration statement | Aug 3, 2021 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Antonio, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1787740
- Former names
- Tivic Health Systems, Inc. (until Apr 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.